Relationship of cardiac troponin T and procoagulant activity in unstable angina

E Giannitsis1, M M Bardorff, S Schweikart

  • 1Medizinische Klinik II der Medizinischen Universität zu Lübeck, Germany.

Insights

Cardiac troponin T (cTnT) levels in unstable angina patients indicate increased procoagulant activity. Elevated cTnT is closely linked to molecular markers of hemostatic activation, aiding in identifying patients needing intensified antithrombotic therapy.

Area of Science:

  • Cardiology
  • Hematology
  • Biochemistry

Background:

  • Unstable angina (UAP) is associated with increased thrombotic risk.
  • Hemostatic activation plays a crucial role in the pathophysiology of UAP.
  • Identifying patients with heightened procoagulant activity is essential for optimizing treatment.

Purpose of the Study:

  • To determine the incidence of increased procoagulant activity in UAP patients.
  • To evaluate the relationship between cardiac troponin T (cTnT) and molecular markers of hemostatic activation.

Main Methods:

  • Studied 44 patients with UAP, stratified by plasma cTnT levels.
  • Administered unfractionated heparin and acetylsalicylic acid to all patients.
  • Serially measured cTnT, fibrin monomers (FM), prothrombin fragments F1+2, thrombin-antithrombin III complexes (TAT), plasminogen, and alpha2-antiplasmin within 48 hours.

Main Results:

  • Increased FM detected in 45.5% of patients, more common with cTnT ≥ 0.1 ng/ml (p=0.003).
  • Significant correlations found between cTnT and FM (r=0.74), and prothrombin fragments F1+2 (r=0.71).
  • cTnT ≥ 0.1 ng/ml showed good sensitivity and specificity for identifying elevated hemostatic markers.

Conclusions:

  • cTnT effectively identifies UAP patients with increased procoagulant activity.
  • cTnT levels correlate closely with molecular markers of hemostatic activation.
  • cTnT alone or combined with other markers can guide more potent antithrombotic therapy decisions.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...